222 related articles for article (PubMed ID: 24187617)
21. College of American Pathologists Tumor Regression Grading System for Long-Term Outcome in Patients with Locally Advanced Rectal Cancer.
Chen HY; Feng LL; Li M; Ju HQ; Ding Y; Lan M; Song SM; Han WD; Yu L; Wei MB; Pang XL; He F; Liu S; Zheng J; Ma Y; Lin CY; Lan P; Huang MJ; Zou YF; Yang ZL; Wang T; Lang JY; Orangio GR; Poylin V; Ajani JA; Wang WH; Wan XB
Oncologist; 2021 May; 26(5):e780-e793. PubMed ID: 33543577
[TBL] [Abstract][Full Text] [Related]
22. Treatment Intensification for Locally Advanced Rectal Cancer: Impact on Pathological Complete Response and Outcomes.
DI Tommaso M; Rosa C; Caravatta L; Augurio A; Borzillo V; DI Santo S; Perrotti F; Taraborrelli M; Cianci R; Innocenti P; DI Sebastiano P; Colasante A; Angelucci D; Basti M; Sindici G; Mazzola L; Pizzicannella G; DI Bartolomeo N; Marchioni M; DI Nicola M; Genovesi D
In Vivo; 2020; 34(3):1223-1233. PubMed ID: 32354913
[TBL] [Abstract][Full Text] [Related]
23. Tumour regression grading in patients with residual rectal cancer after preoperative chemoradiation.
Bujko K; Kolodziejczyk M; Nasierowska-Guttmejer A; Michalski W; Kepka L; Chmielik E; Wojnar A; Chwalinski M;
Radiother Oncol; 2010 Jun; 95(3):298-302. PubMed ID: 20430458
[TBL] [Abstract][Full Text] [Related]
24. Pathological Assessment of the AJCC Tumor Regression Grading System After Preoperative Chemoradiotherapy for Chinese Locally Advanced Rectal Cancer.
Zhang LN; Xiao WW; Xi SY; OuYang PY; You KY; Zeng ZF; Ding PR; Zhang HZ; Pan ZZ; Xu RH; Gao YH
Medicine (Baltimore); 2016 Jan; 95(3):e2272. PubMed ID: 26817863
[TBL] [Abstract][Full Text] [Related]
25. [Study on the relationship between tumor regression grade and lymph node regression grade].
Zhao Q; Fu C; Yu E; Zhang W; Meng R; Wang H; Hao L; Wang H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1050-1054. PubMed ID: 28900999
[TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant chemoradiotherapy might provide survival benefit in patients with stage IIIb/IIIc locally advanced rectal cancer: A retrospective single-institution study with propensity score-matched comparative analysis.
Sun XY; Cai SH; Xu L; Luo D; Qiu HZ; Wu B; Lin GL; Lu JY; Zhang GN; Xiao Y
Asia Pac J Clin Oncol; 2020 Jun; 16(3):142-149. PubMed ID: 32031326
[TBL] [Abstract][Full Text] [Related]
27. Role of dynamic perfusion magnetic resonance imaging in patients with local advanced rectal cancer.
Ippolito D; Drago SG; Pecorelli A; Maino C; Querques G; Mariani I; Franzesi CT; Sironi S
World J Gastroenterol; 2020 May; 26(20):2657-2668. PubMed ID: 32523318
[TBL] [Abstract][Full Text] [Related]
28. [Neoadjuvant radiochemotherapy in the treatment of locally advanced rectal tumors].
Rápolti E; Szigeti A; Farkas R; Bellyei S; Boronkai A; Papp A; Gömöri E; Horváth OP; Mangel L
Magy Onkol; 2009 Dec; 53(4):345-9. PubMed ID: 20071306
[TBL] [Abstract][Full Text] [Related]
29. ypTNM category combined with AJCC tumor regression grade for screening patients with the worst prognosis after neoadjuvant chemoradiation therapy for locally advanced rectal cancer.
Wei J; Huang R; Guo S; Zhang X; Xi S; Wang Q; Chang H; Wang X; Xiao W; Zeng Z; Gao Y
Cancer Manag Res; 2018; 10():5219-5225. PubMed ID: 30464619
[TBL] [Abstract][Full Text] [Related]
30. Impact of perineural and lymphovascular invasion on oncological outcomes in rectal cancer treated with neoadjuvant chemoradiotherapy and surgery.
Cienfuegos JA; Rotellar F; Baixauli J; Beorlegui C; Sola JJ; Arbea L; Pastor C; Arredondo J; Hernández-Lizoáin JL
Ann Surg Oncol; 2015 Mar; 22(3):916-23. PubMed ID: 25190129
[TBL] [Abstract][Full Text] [Related]
31. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer.
Suárez J; Vera R; Balén E; Gómez M; Arias F; Lera JM; Herrera J; Zazpe C
Colorectal Dis; 2008 Jul; 10(6):563-8. PubMed ID: 18070184
[TBL] [Abstract][Full Text] [Related]
32. Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer?
Deantonio L; Caroli A; Puta E; Ferrante D; Apicella F; Turri L; Sacchetti G; Brambilla M; Krengli M
Radiat Oncol; 2018 Oct; 13(1):211. PubMed ID: 30359275
[TBL] [Abstract][Full Text] [Related]
33. Early FDG PET response assessment of preoperative radiochemotherapy in locally advanced rectal cancer: correlation with long-term outcome.
Avallone A; Aloj L; Caracò C; Delrio P; Pecori B; Tatangelo F; Scott N; Casaretti R; Di Gennaro F; Montano M; Silvestro L; Budillon A; Lastoria S
Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1848-57. PubMed ID: 23053320
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcomes in patients with locally advanced rectal cancer treated with preoperative chemoradiation followed by curative surgical resection.
Lim SB; Yu CS; Hong YS; Kim TW; Kim JH; Kim JC
J Surg Oncol; 2012 Nov; 106(6):659-66. PubMed ID: 22674581
[TBL] [Abstract][Full Text] [Related]
35. Comparison of efficacy and safety of preoperative Chemoradiotherapy in locally advanced upper and middle/lower rectal cancer.
Huang MY; Lee HH; Tsai HL; Huang CW; Yeh YS; Ma CJ; Huang CM; Chen CY; Huang JJ; Wang JY
Radiat Oncol; 2018 Mar; 13(1):53. PubMed ID: 29587797
[TBL] [Abstract][Full Text] [Related]
36. Tumor Regression Grade as a Prognostic Factor in Metastatic Colon Cancer Following Preoperative Chemotherapy.
Yang Y; Luo D; Zhang R; Cai S; Li Q; Li X
Clin Colorectal Cancer; 2022 Jun; 21(2):96-106. PubMed ID: 34895989
[TBL] [Abstract][Full Text] [Related]
37. Tumor regression grade in locally advanced rectal cancer after neoadjuvant chemoradiotherapy: influencing factors and prognostic significance.
Lu X; Qi R; Xu Y; Wang X; Cai Y; Wang C
Int J Clin Exp Pathol; 2023; 16(6):124-132. PubMed ID: 37425225
[TBL] [Abstract][Full Text] [Related]
38. Rectal Cancer in Patients with Hereditary Nonpolyposis Colorectal Cancer Compared with Sporadic Cases: Response to Neoadjuvant Chemoradiation and Local Recurrence.
Madbouly KM; Emile SH; Issa YA
J Am Coll Surg; 2022 May; 234(5):793-802. PubMed ID: 35426392
[TBL] [Abstract][Full Text] [Related]
39. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation.
Dudani S; Marginean H; Tang PA; Monzon JG; Raissouni S; Asmis TR; Goodwin RA; Gotfrit J; Cheung WY; Vickers MM
BMC Cancer; 2019 Jul; 19(1):664. PubMed ID: 31277604
[TBL] [Abstract][Full Text] [Related]
40. The potential benefit of adjuvant chemotherapy in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy is not predicted by tumor regression grade.
Bohlok A; Hendlisz A; Bouazza F; Galdon MG; Van de Stadt J; Moretti L; El Nakadi I; Liberale G
Int J Colorectal Dis; 2018 Oct; 33(10):1383-1391. PubMed ID: 29984385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]